[Protective effect of mitochondria-targeted antioxidant peptide SS-31 in sepsis-induced acute kidney injury]
Related Experiment Video
Updated: Oct 4, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Min Sun1, Jianwei Ma, Jihui Ye
1Department of Intensive Care Unit, Ningbo First Hospital, Ningbo 315010, Zhejiang, China. Corresponding author: Zhu Jianhua,
Objective:
To study the effect and mechanism of mitochondria-targeted antioxidant peptide SS-31 on sepsis-induced acute kidney injury (AKI).
Methods:
Sixty adult male C57BL/6 mice were randomly divided into four groups according to the random number table method: sham group (10 mice), positive control group (10 mice), sepsis model group (20 mice), and SS-31 peptide group (20 mice). The sepsis-induced AKI mouse model was reproduced by cecal ligation and puncture (CLP). The sham group only received laparotomy. SS-31 peptide (5 mg/kg) was intraperitoneally injected in SS-31 peptide group and positive control group 30 minutes after the operation, while an equivalent amount of normal saline was given in sham group and sepsis model group for 7 days. The blood samples were collected 24 hours after the operation from orbit, and the serum was collected to test the serum creatinine (SCr) and blood urea nitrogen (BUN). The mice were sacrificed 7 days after surgery. The kidney tissues were collected to observe the pathologic structure changes under the hematoxylin-eosin (HE) staining by light microscope. And the mitochondrial ultrastructure was checked under the transmission electron microscope. Cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling method (TUNEL). The expression level of peroxisome proliferator-activated receptorγ coactivator-1α (PGC-1α), adenosine monophosphate-activated protein kinase (AMPK), and cleaved caspase-3 protein were tested by Western blotting.
Results:
Compared with sham group, the levels of SCr and BUN were significantly increased in sepsis model group [SCr (μmol/L): 93.12±11.80 vs. 32.94±3.37, BUN (mmol/L): 41.36±6.48 vs. 9.49±3.58, both P < 0.05]. The expression levels of AMPK, PGC-1α and cleaved caspase-3 protein increased (AMPK/β-actin: 0.30±0.02 vs. 0.12±0.01, PGC-1α/β-actin: 0.38±0.03 vs. 0.16±0.02, cleaved caspase-3/β-actin: 0.20±0.01 vs. 0.11±0.02, all P < 0.05). HE staining showed that inflammatory cell was infiltrated, glomerular basement membrane was exposed and vacuole-like transparent casts were found in the lumen. Mitochondria were damaged under electron microscope with swelling, ridge disappearance and ruptured membranes, with increasing of apoptotic cells [cells: 24.00 (18.75, 31.00) vs. 2.00 (0.72, 3.25), P < 0.05]. Meanwhile, compared with sepsis model group, the levels of SCr, BUN and the expressions of AMPK, PGC-1α, cleaved caspase-3 protein were significantly decreased in the SS-31 peptide group [SCr (μmol/L): 71.33±10.14 vs. 93.12±11.80, BUN (mmol/L): 27.00±5.52 vs. 41.36±6.48, AMPK/β-actin: 0.23±0.01 vs. 0.30±0.02, PGC-1α/β-actin: 0.27±0.02 vs. 0.38±0.03, cleaved caspase-3/β-actin: 0.13±0.01 vs. 0.20±0.01, all P < 0.05]. HE staining showed that cell swelling reduced, the mitochondrial structure was intact, the ridge swelling was also reduced, and the membrane structure was relatively intact, the number of apoptotic cells was significantly reduced [cells: 13.00 (9.00, 16.50) vs. 24.00 (18.75, 31.00), P < 0.05].
Conclusions:
The protective effect of SS-31 peptide on organ dysfunction induced by sepsis-induced AKI is related to maintaining mitochondrial homeostasis and inhibiting cell apoptosis.
Insights
Mitochondria-targeted antioxidant peptide SS-31 protects against sepsis-induced acute kidney injury (AKI) by maintaining mitochondrial function and reducing cell apoptosis. This study highlights SS-31 as a potential therapeutic agent for AKI.
Area of Science:
- Nephrology
- Mitochondrial Medicine
- Sepsis Research
Background:
- Sepsis-induced acute kidney injury (AKI) is a critical complication with high mortality.
- Mitochondrial dysfunction plays a key role in the pathogenesis of sepsis-induced AKI.
- Targeting mitochondria offers a potential therapeutic strategy for AKI.
Purpose of the Study:
- To investigate the protective effects and underlying mechanisms of the mitochondria-targeted antioxidant peptide SS-31 on sepsis-induced AKI.
- To evaluate the impact of SS-31 on renal function, mitochondrial integrity, and apoptosis in a mouse model of sepsis-induced AKI.
Main Methods:
- A mouse model of sepsis-induced AKI was established using cecal ligation and puncture (CLP).
- Mice were treated with SS-31 peptide or saline.
- Renal function markers (serum creatinine, BUN), kidney histopathology, mitochondrial ultrastructure, and apoptosis were assessed.
- Expression levels of AMPK, PGC-1α, and cleaved caspase-3 were determined via Western blotting.
Main Results:
- Sepsis significantly increased serum creatinine and BUN levels, induced kidney damage, mitochondrial dysfunction, and apoptosis.
- SS-31 treatment markedly reduced serum creatinine and BUN levels, alleviated kidney histopathological damage, preserved mitochondrial structure, and decreased apoptosis.
- SS-31 administration modulated the expression of AMPK, PGC-1α, and cleaved caspase-3.
Conclusions:
- SS-31 peptide demonstrates significant protective effects against sepsis-induced AKI.
- The mechanism involves maintaining mitochondrial homeostasis and inhibiting cell apoptosis.
- SS-31 represents a promising therapeutic candidate for managing sepsis-induced AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

